Owkin and University Hospitals Birmingham NHS Foundation Trust (UHB) have announced a new five year research partnership to use artificial intelligence (AI) to accelerate the screening and diagnosis of a range of diseases, starting with colorectal cancer.
Colorectal cancer is the third most common cancer type worldwide, with almost 2 million cases of colorectal cancer diagnosed each year. Early detection significantly increases the chances of successful treatment. AI powered diagnostics have the potential to accelerate the screening process, playing a crucial role in facilitating earlier intervention which often leads to better patient outcomes.
To find out more about the types of research projects involved in this partnership and the full press release:
Owkin and University Hospitals Birmingham collaborate to use AI diagnostics in a study that may diagnose and help treat colorectal cancer quicker – Owkin: Owkin and University Hospitals Birmingham collaborate to use AI diagnostics in a study that may diagnose and help treat colorectal cancer quicker